SCI & TECH● LOWSep 27 · Sep 27, 2026, 5:15 AM
2026 IMS | IASO Bio Presented First - in - Human Data of BCMA - Targeted In Vivo CAR - T Cell Therapy IASO206
prnewswire.com · United States · global
IASO Bio presented initial human data for a new BCMA-targeted CAR-T cell therapy at the 2026 IMS conference. This represents a potentially important advancement in medical treatment.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
See it on the live mapUnited States and nearby eventsMore from United StatesLatest stories and threat level
More from United States
BUSINESS8h agoWhat's most watched on Netflix United States: the 10 most successful series of the moment, with "Under the Surface: miniseries" at the topClarínPOLITICS11h agoNo, this oil tanker didn’t carry Russian diesel to the United StatesFrance 24 [en]POLITICS1d agoBehind the deal between the United States and Russia, the good business of Donald Trump and his relativesLe Figaro InternationalMILITARY1d agoUnited States will send 'hundreds' of soldiers to Latin America: NYTLa Silla Vacía
More in Sci & Tech
SCI & TECH15m agoiPhone Duo already backordered until 2027 as pre-order sales soarCBS NewsSCI & TECH17m agoFG to deploy 3,700 telecom towers to connect 20m NigeriansVanguard NigeriaSCI & TECH28m agoBiomemory Launches DNA Shield, First Commercial Product Built on Its Molecular IT PlatformDark ReadingSCI & TECH35m agoAI surveillance , conspiring bots on watchdog radarillawarramercury.com.au · Australia